GLOW (Blend)

The Copper Question in This Blend

UKPWritten and published by UK Peptides2 min readUpdated 5 cited sources

The short answer

Copper is a redox-active metal that catalyses oxidation of thiols and thioethers, so co-lyophilising a copper complex with other peptides is a legitimate chemical question. BPC-157 has no cysteine or methionine. TB-500, supplied here as full-length thymosin beta-4, has no cysteine but one methionine, so that one residue is where the concern applies.

Key facts

Copper source
GHK-Cu complex, Cu(II)
Copper property
Redox-active, catalytic
Would attack
Cysteine thiols, methionine thioethers
BPC-157 sequence
GEPPPGKPADDAGLV (neither present)
TB-500 (thymosin beta-4)
No cysteine; one methionine
Conclusion
Limited to TB-500's one methionine

Why the question is worth asking

Copper catalyses oxidation, and the GLOW blend carries a copper complex. In protein chemistry this is well established: trace copper accelerates thiol oxidation, disulfide scrambling and methionine oxidation, which is why chelating agents appear in so many protein formulation buffers. Putting a copper complex in a vial with other peptides is therefore a fair thing to interrogate rather than assume away.

What copper would attack

Two residues specifically. Cysteine, whose free thiol is the most readily oxidised side chain in the standard set; copper-catalysed thiol oxidation is fast enough to be a formulation problem. And methionine, whose thioether oxidises to the sulfoxide, adding 16 Da and often reducing activity.

Research material referenced

GLOW 70mg, third-party HPLC tested

Buy GLOW · £59.99

What is actually in the vial

In the GLOW 70mg vial, BPC-157 is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. No cysteine. No methionine. TB-500 here is full-length thymosin beta-4, 43 residues, with no cysteine but one methionine at position 6. So the thiol chemistry copper would catalyse has no substrate in the vial, and the thioether chemistry has exactly one.

Why this is a real finding rather than a reassurance

Because it would not have held for many other combinations. Glutathione is defined by a free thiol and oxidises to GSSG in air without any catalyst, so pairing it with a copper complex would be actively poor chemistry. IGF-1 LR3 carries three disulfide bonds whose correct pairing matters, and copper promotes disulfide scrambling. Neither belongs in a vial with GHK-Cu. This set avoids the thiol and disulfide problems entirely; what remains is one methionine.

What copper does not exempt the blend from

Ordinary hydrolysis, physical loss to surfaces, and the general instability of any peptide in solution. The copper question is narrow here; it is not the only question. GHK-Cu itself is also the component whose identity is most often misstated, with free GHK at 340.38 Da regularly quoted in place of the complex at 402.92.

How to check

A copper-catalysed oxidation product would show as a mass increase, most characteristically +16 Da on a methionine-containing peptide. In this blend that means the TB-500 component: a +16 Da species beside thymosin beta-4's 4,963 Da is the signature to look for, and the reason the vial is kept dry, cold and dark.

Frequently asked questions

Is it safe to blend a copper peptide with other peptides?

It depends entirely on the other peptides. Copper attacks cysteine thiols and methionine thioethers. BPC-157 contains neither; TB-500, as full-length thymosin beta-4, contains one methionine.

Which peptides should not be blended with copper?

Anything with a free thiol or disulfide bonds. Glutathione and IGF-1 LR3 are clear examples from this catalogue.

How would copper damage show up?

Most characteristically as a +16 Da oxidation satellite. Here it would appear on the TB-500 component, which carries the blend's one methionine.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More GLOW (Blend) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.